Smart microrobots that can adapt to their surroundings

One day we may be able to ingest tiny robots that deliver drugs directly to diseased tissue, thanks to research being carried out at EPFL and ETH Zurich. The group of scientists - led by Selman Sakar at EPFL and Bradley Nelson at ETH Zurich - drew inspiration from bacteria to design smart, biocompatible microrobots that are highly flexible. Because these devices are able to swim through fluids and modify their shape when needed, they can pass through narrow blood vessels and intricate systems without compromising on speed or maneuverability. They are made of hydrogel nanocomposites that contain magnetic nanoparticles allowing them to be controlled via an electromagnetic field.

In an article appearing in Science Advances, the scientists describe the method they have developed for "programming" the robot's shape so that it can easily travel through fluids that are dense, viscous or moving at rapid speeds.

Embodied intelligence

When we think of robots, we generally think of bulky machines equipped with complex systems of electronics, sensors, batteries and actuators. But on a microscopic scale, robots are entirely different.

Fabricating miniaturized robots presents a host of challenges, which the scientists addressed using an origami-based folding method. Their novel locomotion strategy employs embodied intelligence, which is an alternative to the classical computation paradigm that is performed by embedded electronic systems. "Our robots have a special composition and structure that allow them to adapt to the characteristics of the fluid they are moving through. For instance, if they encounter a change in viscosity or osmotic concentration, they modify their shape to maintain their speed and maneuverability without losing control of the direction of motion," says Sakar.

These deformations can be "programmed" in advance so as to maximize performance without the use of cumbersome sensors or actuators. The robots can be either controlled using an electromagnetic field or left to navigate on their own through cavities by utilizing fluid flow. Either way, they will automatically morph into the most efficient shape.

Inspired by nature

"Nature has evolved a multitude of microorganisms that change shape as their environmental conditions change. This basic principle inspired our microrobot design. The key challenge for us was to develop the physics that describe the types of changes we were interested in, and then to integrate this with new fabrication technologies," says Nelson. In addition to offering enhanced effectiveness, these miniaturized soft robots can also be manufactured easily at a reasonable cost. For now, the research team is working on improving the performance for swimming through complex fluids like those found in the human body.

H W Huang, F E Uslu, P Katsamba, E Lauga, M S Sakar, B J Nelson.
Adaptive locomotion of artificial microswimmers.
Science Advances 18 Jan 2019: Vol. 5, no. 1. doi: 10.1126/sciadv.aau1532.

Most Popular Now

Forxiga receives positive EU CHMP opinion for the …

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended a new indication for the marketing authorisation of Forxi...

Merck Granted U.S. Patent for novel combination of…

Merck, a leading science and technology company, today announced that it has been granted Patent No. US 10,193,695 by the United States Patent and Trademark Office (USPTO...

Pfizer receives positive CHMP opinion for Vizimpro…

Pfizer today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending V...

US FDA grants Breakthrough Therapy Designation for…

AstraZeneca and its global biologics research and development arm, MedImmune, today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Ther...

Merck to expand US biopharmaceutical R&D facil…

Merck, a leading science and technology company, today announced a $70 million investment to expand its state of the art research and development (R&D) facility in Biller...

New pill can deliver insulin

An MIT-led research team has developed a drug capsule that could be used to deliver oral doses of insulin, potentially replacing the injections that people with type 2 di...

Amgen and UCB receive positive vote from FDA Advis…

Amgen (NASDAQ:AMGN) and UCB (Euronext Brussels: UCB) announced strong support from the U.S. Food and Drug Administration (FDA) Bone, Reproductive and Urologic Drugs Advis...

Pfizer and Lilly announce top-line results from se…

Pfizer Inc. (NYSE:PFE) and Eli Lilly and Company (NYSE:LLY) today announced positive top-line results from a Phase 3 study evaluating tanezumab 2.5 mg or 5 mg in patients...

Merck and Tencent announce collaboration on intell…

Merck, a leading science and technology company, signed a strategic collaboration agreement with Tencent, a leading provider of Internet value added services. The collabo...

Cannabinoid compounds may inhibit growth of colon …

Medical marijuana has gained attention in recent years for its potential to relieve pain and short-term anxiety and depression. Now, Penn State College of Medicine resear...

Researchers call for big data infrastructure to su…

Researchers from the George Washington University (GW), the U.S. Food and Drug Administration (FDA), and industry leaders published in PLOS Biology, describing a standard...

New computational method reduces risk of drug form…

One major factor that determines the efficacy of a drug is the structure that its molecules form in a solid state. Changed molecular structures can entail that pills stop...